[HTML][HTML] Tofacitinib inhibits granulocyte–macrophage colony-stimulating factor-induced NLRP3 inflammasome activation in human neutrophils

MY Furuya, T Asano, Y Sumichika, S Sato… - Arthritis research & …, 2018 - Springer
Background Granulocyte–macrophage colony-stimulating factor (GM-CSF) has emerged as
a crucial cytokine that activates myeloid cells to initiate tissue inflammation. However, the …

[HTML][HTML] Real-World Effectiveness of Belimumab in Patients with Active Lupus

Y Sumichika, S Yoshida, E Suzuki, K Saito… - Journal of Clinical …, 2023 - mdpi.com
This study evaluated the real-world effectiveness of belimumab (BLM) in the treatment of
systemic lupus erythematosus (SLE) patients with moderate to high disease activity. This …

[HTML][HTML] Increased CEACAM1 expression on peripheral blood neutrophils in patients with rheumatoid arthritis

H Matsumoto, Y Fujita, M Onizawa, K Saito… - Frontiers in …, 2022 - frontiersin.org
Altered expression of adhesion molecules in immune cells has been demonstrated in
rheumatoid arthritis (RA). Carcinoembryonic–antigen–related cell–adhesion molecule 1 …

Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse

S Sato, XK Zhang, N Matsuoka, Y Sumichika… - Lupus Science & …, 2023 - lupus.bmj.com
Objective Friend leukaemia virus integration 1 (Fli-1) regulates chemokine/cytokine
expression and thus plays an important role in the development of lupus nephritis …

[HTML][HTML] Drug retention rates and the safety of Janus kinase inhibitors in elderly patients with rheumatoid arthritis

J Temmoku, M Miyata, E Suzuki, Y Sumichika… - Journal of Clinical …, 2023 - mdpi.com
Background: We examined the real-world drug retention rate and safety data of Janus
kinase inhibitors (JAKis) in elderly patients with rheumatoid arthritis (RA). Methods: This …

[HTML][HTML] Effectiveness of Colchicine or Canakinumab in Japanese Patients with Familial Mediterranean Fever: A Single-Center Study

S Yoshida, Y Sumichika, K Saito, H Matsumoto… - Journal of Clinical …, 2023 - mdpi.com
Background: To investigate the clinical features of Japanese patients with Familial
Mediterranean Fever (FMF), we evaluated the frequency of attacks, treatment responses …

Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines

S Yoshida, T Koga, Y Fujita, H Yatsuhashi… - Frontiers in …, 2024 - frontiersin.org
Background Autoinflammation with cytokine dysregulation may be implicated in the
pathophysiology of adult-onset Still's disease (AOSD); however, the relationship between …

Adult-onset Still's Disease with Acute Kidney Injury Requiring Hemodialysis: A Case Report and Literature Review

K Saito, J Temmoku, Y Sumichika, S Yoshida… - Internal …, 2023 - jstage.jst.go.jp
Adult-onset Still's disease (AOSD) is characterized by high spiking fever, evanescent rash,
and arthritis. However, AOSD rarely presents with severe acute kidney injury (AKI). We …

New-onset Systemic Lupus Erythematosus Manifestation Following COVID-19: A Case Report and Literature Review

Y Sumichika, J Temmoku, K Saito, S Yoshida… - Internal …, 2024 - jstage.jst.go.jp
Coronavirus disease 2019 (COVID-19) is a respiratory viral disease, and several cases of
autoimmune diseases have been reported after infection. This report presents the case of a …

[HTML][HTML] Comparing the effectiveness and safety of Abatacept and Tocilizumab in elderly patients with rheumatoid arthritis

J Temmoku, M Miyata, E Suzuki, Y Sumichika, K Saito… - Plos one, 2022 - journals.plos.org
Background The number of biological DMARDs (bDMARDs) used in elderly patients with
rheumatoid arthritis (RA) has increased in recent years. We aimed to compare the drug …